Skip to main content

Advertisement

Log in

Allogeneic PBPC transplantation: an effect on incidence and distribution of chronic graft-versus-host disease without long-term survival benefit?

  • Correspondence
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Russell NH, Gratwohl A, Schmitz N . Developments in allogeneic peripheral blood progenitor cell transplantation Br J Haematol 1998 103: 594–600

    Article  CAS  Google Scholar 

  2. Storek J, Gooley T, Siadak M et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease Blood 1998 90: 4705–4709

    Google Scholar 

  3. Korbling M, Mirza N, Przepiorka D et al. Clinical outcome of 112 patients following HLA-identical allogeneic peripheral blood stem cell transplantation Blood 1997 100: (Suppl 1) 224a

    Google Scholar 

  4. Socie G, Stone JV, Wingard JR et al. Long-term survival and late deaths after allogeneic bone marrow transplantation New Engl J Med 1999 341: 14–21

    Article  CAS  Google Scholar 

  5. Atkinson K, Downs K . Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplant 1995 16: 755–758

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the Arrow Foundation for their support.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Snowden, J., Nivison-Smith, I., Atkinson, K. et al. Allogeneic PBPC transplantation: an effect on incidence and distribution of chronic graft-versus-host disease without long-term survival benefit?. Bone Marrow Transplant 25, 119–120 (2000). https://doi.org/10.1038/sj.bmt.1702090

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702090

  • Springer Nature Limited

This article is cited by

Navigation